Related Experiment Video
Updated: May 30, 2026
05:12
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
Published on: May 12, 2023
Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients
Damiano Gullo1, Adele Latina, Francesco Frasca
1Endocrine Unit, Department of Clinical and Molecular Biomedicine, University of Catania Medical School, Garibaldi-Nesima Hospital, Catania, Italy. damiano.gullo@poste.it
Plos One
|August 11, 2011
Summary
Levothyroxine monotherapy may not adequately normalize thyroid hormone levels in all hypothyroid patients. Many experience abnormal thyroid hormone ratios, suggesting a need for alternative treatments.
Area of Science:
- Endocrinology
- Thyroidology
Background:
- Levothyroxine (L-T4) monotherapy is standard for hypothyroidism, assuming peripheral conversion of T4 to T3 meets hormonal needs.
- However, evidence suggests this conversion may be insufficient in some individuals.
Purpose of the Study:
- To assess if levothyroxine monotherapy normalizes thyroid hormones and pituitary feedback in athyreotic patients.
- To investigate the heterogeneity of peripheral T3 production.
Main Methods:
- Retrospective study of 1,811 athyreotic patients on levothyroxine monotherapy with normal TSH.
- Comparison with 3,875 euthyroid controls.
- Measurement of TSH, FT4, and FT3 levels.
Main Results:
- Levothyroxine-treated patients showed higher FT4 and lower FT3 levels than controls (p<0.001).
- 15.2% had low FT3, and 7.2% had high FT4.
- Significant heterogeneity in FT3/FT4 ratios indicated variable T3 production capacity.
Conclusions:
- Athyreotic patients exhibit diverse T3 production from levothyroxine.
- Over 20% have abnormal FT3 or FT4 despite normal TSH, indicating inadequate peripheral conversion.
- Abnormal pituitary response suggests levothyroxine monotherapy may not be optimal for all hypothyroid patients.
Related Concept Videos
01:23Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...